Back
Speaker illustration

Doctor Bernhard Ohnewein

Paracelsus Private Medical University, Salzburg (Austria)

Presentations

Effects of angiotensin receptor-neprilysin inhibitors (ARNIs) on the glucose and fat metabolism biomarkers leptin and fructosamin

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Neprilysin inhibition: news and nuggets

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources